Rubrik: Aktuelle Epidemiologie und Diagnostik in der Mikrobiologie
Ein Virus macht sie auf den Weg (S. 47)
1. Bert F, Scaioli G, Gualano MR, Passi S, Specchia ML, Cadeddu C, Viglianchino C, Siliquini R. Norovirus outbreaks on commercial cruise ships: a systematic review and new targets for the public health agenda. Food Environ Virol 2014 ;6 (2): 67-74. doi: 10.1007/s12560-014-9145-5.
2. Carling PC, Bruno-Murtha LA, Griffiths JK. Cruise ship environmental hygiene and the risk of norovirus infection outbreaks: an objective assessment of 56 vessels over 3 years. Clin Infect Dis 2009; 49 (9): 1312-1307. doi: 10.1086/606058.
3. Miller JM, Tam TW, Maloney S, Fukuda K, Cox N, Hockin J, Kertesz D, Klimov A, Cetron M. Cruise ships: high-risk passengers and the global spread of new influenza viruses. Clin Infect Dis 2000; 31 (2): 433-438. doi: 10.1086/313974.
4. Marti F, Steffen R, Mutsch M. Influenza vaccine: a travelers' vaccine? Expert Rev Vaccines 2008; 7 (5): 679-687. doi: 10.1586/14760584.7.5.679.
5. Young BE, Wilder-Smith A. Influenza on cruise ships. J Travel Med 2018; 25 (1): 1-2. doi: 10.1093/jtm/tay146.
6. Goutziana G, Mouchtouri VA, Karanika M, Kavagias A, Stathakis NE, Gourgoulianis K, Kremastinou J, Hadjichristodoulou C. Legionella species colonization of water distribution systems, pools and air conditioning systems in cruise ships and ferries. BMC Public Health 2008; 8: 390. doi: 10.1186/1471-2458-8-390.
7. Mouchtouri VA, Rudge JW. Legionnaires' disease in hotels and passenger Ships: a systematic review of evidence, sources, and contributing factors. J Travel Med. 2015 Sep-Oct;22(5):325-37. doi: 10.1111/jtm.12225.
8. Laganà P, Gambuzza M E, Delia S. Legionella risk assessment in cruise ships and ferries. Ann Agric Environ Med 2017; 24 (2): 276-282. doi: 10.26444/aaem/74717.
9. Kupferschmidt K. Cruise ship outbreak spotlights a little-studied hantavirus. Science 2026; 392 (6799): 672-673. doi: 10.1126/science.aei8221.
10. Andes Virus Outbreak Working Group. Andes Hantavirus outbreak on a cruise ship, 2026. NEJM Evid 2026; 5 (6): EVIDpha2600170. doi: 10.1056/EVIDpha2600170.
11. Oceanwide Expeditions. https://oceanwide-expeditions.com/de/unsere-schiffe/m-v-hondius-1
12. World Health Organization (WHO). Hantavirus cluster linked to cruise ship travel, multi-country. https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON599
13. New York Post. Patient Zero’ in deadly hantavirus cruise ship outbreak was Dutch ornithologist Leo Schilperoord. https://nypost.com/2026/05/09/world-news/hantavirus-patient-zero-was-dutch-ornithologist-leo-schilperoord
14. European Centre for Disease Prevention and Control (ECDC). Andes hantavirus outbreak in cruise ship. https://www.ecdc.europa.eu/en/infectious-disease-topics/hantavirus-infection/surveillance-and-updates/andes-hantavirus-outbreak
15. World Health Organization (WHO). Hantavirus outbreak linked to cruise ship travel, multi-locations. https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON611
16. European Centre for Disease Prevention and Control (ECDC). Guidance for the management of passengers linked to the Andes hantavirus outbreak on cruise ship. https://www.ecdc.europa.eu/en/news-events/ecdc-publishes-guidance-management-passengers-linked-andes-hantavirus-outbreak-cruise
17. World Health Organization (WHO). Management of contacts of Andes virus (ANDV) cases from the MV Hondius cruise ship. https://www.who.int/publications/m/item/management-of-contacts-of-andes-virus-(andv)-cases-fromthe-mv-hondius-cruise-ship
18. Urmi UL, Willcox MDP. From Norovirus to Andes Hantavirus: Indirect viral transmission and emerging prevention strategies for cruise ship and confined environments. Rev Med Virol 2026; 36 (4): e70180. doi: 10.1002/rmv.70180.
19. Lee HW, Lee PW, Johnson KM. Isolation of the etiologic agent of Korean Hemorrhagic fever. J Infect Dis 1978; 137 (3): 298-308. doi: 10.1093/infdis/137.3.298.
20. Robert Koch Institut (RKI). RKI-Ratgeber Hantavirus-Erkrankung (Stand: 11/2020). https://www.rki.de/DE/Aktuelles/Publikationen/RKI-Ratgeber/Ratgeber/Ratgeber_Hantaviren.html
21. Robert Koch Institut (RKI). Falldefinitionen des RKI 2026: Hantavirus-Erkrankung (Hantavirus). https://www.rki.de/DE/Themen/Infektionskrankheiten/Meldewesen/Falldefinitionen/Downloads/Hantavirus.pdf
22. Bourquain D, Bodenstein C, Schürer S, Schaade L. Puumala and Tula Virus differ in replication kinetics and innate immune stimulation in human endothelial cells and macrophages. Viruses 2019; 11 (9): 855. doi: 10.3390/v11090855.
23. Avšič-Županc T, Saksida A, Korva M. Hantavirus infections. Clin Microbiol Infect 2019; 21S: e6-e16. doi: 10.1111/1469-0691.12291.
24. Vial PA, Ferrés M, Vial C, Klingström J, Ahlm C, López R, Le Corre N, Mertz GJ. Hantavirus in humans: a review of clinical aspects and management. Lancet Infect Dis 2023; 23 (9): e371-e382. doi: 10.1016/S1473-3099(23)00128-7.
25. Robert Koch Institut (RKI). SurvStat@RKI 2.0. https://survstat.rki.de
26. Centers for Disease Control and Prevention (CDC). Reported cases of Hantavirus disease. https://www.cdc.gov/hantavirus/data-research/cases/index.html
27. Tortosa F, Perre F, Tognetti C, Lossetti L, Carrasco G, Guaresti G, Iglesias A, Espasandin Y, Izcovich A. Seroprevalence of hantavirus infection in non-epidemic settings over four decades: a systematic review and meta-analysis. BMC Public Health 2024; 24 (1): 2553. doi: 10.1186/s12889-024-20014-w.
28. World Health Organization (WHO). Hantavirus. https://www.who.int/news-room/fact-sheets/detail/hantavirus
